Analysis of the Efficacy and the Long-term Metabolic and Nutritional Status of Sleeve Gastrectomy with Transit Bipartition Compared to Roux-en-Y Gastric Bypass in Obese Rats
Purpose Sleeve gastrectomy with transit bipartition (SG-TB) could be an attractive alternative to Roux-en-Y gastric bypass (RYGB) on weight loss and improvement of comorbidities in patients with obesity. However, there is little long-term data. Translational research on a rat model could allow long-...
Gespeichert in:
| Veröffentlicht in: | Obesity surgery 2023-04, Vol.33 (4), p.1121-1132 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1132 |
|---|---|
| container_issue | 4 |
| container_start_page | 1121 |
| container_title | Obesity surgery |
| container_volume | 33 |
| creator | Baratte, Clement Willemetz, Alexandra Ribeiro-Parenti, Lara Carette, Claire Msika, Simon Bado, Andre Czernichow, Sebastien Le Gall, Maude Poghosyan, Tigran |
| description | Purpose
Sleeve gastrectomy with transit bipartition (SG-TB) could be an attractive alternative to Roux-en-Y gastric bypass (RYGB) on weight loss and improvement of comorbidities in patients with obesity. However, there is little long-term data. Translational research on a rat model could allow long-term projection to assess efficacy and safety of SG-TB. The aim of this research was to evaluate the long-term efficacy and safety of SG-TB compared to RYGB and SHAM in rat model.
Materials and Methods
Ninety-four male obese Wistar rats were distributed into 3 groups: SG-TB (
n
= 34), RYGB (
n
= 32), and SHAM (control group,
n
= 28). The percentage of total weight loss (%TWL), coprocalorimetry, glucose and insulin tolerance test, insulin, GLP-1, PYY, and GIP before and after surgery were assessed. The animals were followed over 6 months (equivalent to 16 years in humans).
Results
At 6 months, %TWL was significantly greater(
p
= 0.025) in the SG-TB group compared to the RYGB group. There was no difference between the groups (
p
= 0.86) in malabsorption 15 and 120 days postoperatively. Glucose tolerance was significantly improved (
p
= 0.03) in the SG-TB and RYGB groups compared to the preoperative state. Insulin secretion, at 3 months, was significantly more important in the SG-TB group (
p
= 0.0003), compared to the RYGB and SHAM groups. GLP-1 secretion was significantly increased in the SG-TB and RYGB groups compared to the preoperative state (
p
= 0.001) but similar between SG-TB and RYGB animals (
p
= 0.72).
Conclusion
In a rat model, at long term compared to RYGB, SG-TB provides greater and better-maintained weight loss and an increased insulin secretion without impairing nutritional status
.
Graphical Abstract |
| doi_str_mv | 10.1007/s11695-023-06477-7 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_03971192v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2796667263</sourcerecordid><originalsourceid>FETCH-LOGICAL-c360t-51ad3f1974ca9af5c99da19fba52abea557604e544716f34cddfa66e732ba3f53</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhSMEokPhBVggS2xgYfBPYo-X01FpkQYqtWXByrpJ7I6rJJ7aTiEPxTvimZQisWBl-d7vnGP5FMVrSj5QQuTHSKlQFSaMYyJKKbF8UiyoJEtMSrZ8WiyIEgQvFeNHxYsYbwlhVDD2vDjiQjLFBV8Uv1YDdFN0EXmL0tagU2tdA82EYGgPg40fbnAyoUdfTILad6457L6OKbjkfNajqwRpPFhcdcbcG3QGMQXTJN9P6IdLW3QdYIguoRO3g5AOOrT2fb6YHOPRpR9_YjPg77M0Z5xMO4gRuQFd1CYadAkpviyeWeiiefVwHhffPp1er8_x5uLs83q1wQ0XJOGKQsstVbJsQIGtGqVaoMrWUDGoDVSVFKQ0VVlKKiwvm7a1IISRnNXAbcWPi_ez7xY6vQuuhzBpD06frzZ6PyNcSUoVu6eZfTezu-DvRhOT7l1sTNfBYPwYNZOSqrIkdI--_Qe99WPIH7inlBC5FcEzxWaqCT7GYOzjCyjR--L1XLzOxetD8Vpm0ZsH67HuTfso-dN0BvgMxLwabkz4m_0f29-MU7oq</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2796667263</pqid></control><display><type>article</type><title>Analysis of the Efficacy and the Long-term Metabolic and Nutritional Status of Sleeve Gastrectomy with Transit Bipartition Compared to Roux-en-Y Gastric Bypass in Obese Rats</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Baratte, Clement ; Willemetz, Alexandra ; Ribeiro-Parenti, Lara ; Carette, Claire ; Msika, Simon ; Bado, Andre ; Czernichow, Sebastien ; Le Gall, Maude ; Poghosyan, Tigran</creator><creatorcontrib>Baratte, Clement ; Willemetz, Alexandra ; Ribeiro-Parenti, Lara ; Carette, Claire ; Msika, Simon ; Bado, Andre ; Czernichow, Sebastien ; Le Gall, Maude ; Poghosyan, Tigran</creatorcontrib><description>Purpose
Sleeve gastrectomy with transit bipartition (SG-TB) could be an attractive alternative to Roux-en-Y gastric bypass (RYGB) on weight loss and improvement of comorbidities in patients with obesity. However, there is little long-term data. Translational research on a rat model could allow long-term projection to assess efficacy and safety of SG-TB. The aim of this research was to evaluate the long-term efficacy and safety of SG-TB compared to RYGB and SHAM in rat model.
Materials and Methods
Ninety-four male obese Wistar rats were distributed into 3 groups: SG-TB (
n
= 34), RYGB (
n
= 32), and SHAM (control group,
n
= 28). The percentage of total weight loss (%TWL), coprocalorimetry, glucose and insulin tolerance test, insulin, GLP-1, PYY, and GIP before and after surgery were assessed. The animals were followed over 6 months (equivalent to 16 years in humans).
Results
At 6 months, %TWL was significantly greater(
p
= 0.025) in the SG-TB group compared to the RYGB group. There was no difference between the groups (
p
= 0.86) in malabsorption 15 and 120 days postoperatively. Glucose tolerance was significantly improved (
p
= 0.03) in the SG-TB and RYGB groups compared to the preoperative state. Insulin secretion, at 3 months, was significantly more important in the SG-TB group (
p
= 0.0003), compared to the RYGB and SHAM groups. GLP-1 secretion was significantly increased in the SG-TB and RYGB groups compared to the preoperative state (
p
= 0.001) but similar between SG-TB and RYGB animals (
p
= 0.72).
Conclusion
In a rat model, at long term compared to RYGB, SG-TB provides greater and better-maintained weight loss and an increased insulin secretion without impairing nutritional status
.
Graphical Abstract</description><identifier>ISSN: 0960-8923</identifier><identifier>EISSN: 1708-0428</identifier><identifier>DOI: 10.1007/s11695-023-06477-7</identifier><identifier>PMID: 36729363</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Animal biology ; Animals ; Gastrectomy ; Gastric Bypass ; Gastrointestinal surgery ; Glucagon-Like Peptide 1 ; Glucose ; Humans ; Insulin ; Life Sciences ; Male ; Medicine ; Medicine & Public Health ; Nutritional Status ; Obesity - surgery ; Obesity, Morbid - surgery ; Original Contributions ; Rats ; Rats, Wistar ; Retrospective Studies ; Surgery ; Treatment Outcome ; Weight Loss</subject><ispartof>Obesity surgery, 2023-04, Vol.33 (4), p.1121-1132</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c360t-51ad3f1974ca9af5c99da19fba52abea557604e544716f34cddfa66e732ba3f53</cites><orcidid>0000-0002-7103-1088 ; 0000-0002-5372-4585</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11695-023-06477-7$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11695-023-06477-7$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36729363$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-03971192$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Baratte, Clement</creatorcontrib><creatorcontrib>Willemetz, Alexandra</creatorcontrib><creatorcontrib>Ribeiro-Parenti, Lara</creatorcontrib><creatorcontrib>Carette, Claire</creatorcontrib><creatorcontrib>Msika, Simon</creatorcontrib><creatorcontrib>Bado, Andre</creatorcontrib><creatorcontrib>Czernichow, Sebastien</creatorcontrib><creatorcontrib>Le Gall, Maude</creatorcontrib><creatorcontrib>Poghosyan, Tigran</creatorcontrib><title>Analysis of the Efficacy and the Long-term Metabolic and Nutritional Status of Sleeve Gastrectomy with Transit Bipartition Compared to Roux-en-Y Gastric Bypass in Obese Rats</title><title>Obesity surgery</title><addtitle>OBES SURG</addtitle><addtitle>Obes Surg</addtitle><description>Purpose
Sleeve gastrectomy with transit bipartition (SG-TB) could be an attractive alternative to Roux-en-Y gastric bypass (RYGB) on weight loss and improvement of comorbidities in patients with obesity. However, there is little long-term data. Translational research on a rat model could allow long-term projection to assess efficacy and safety of SG-TB. The aim of this research was to evaluate the long-term efficacy and safety of SG-TB compared to RYGB and SHAM in rat model.
Materials and Methods
Ninety-four male obese Wistar rats were distributed into 3 groups: SG-TB (
n
= 34), RYGB (
n
= 32), and SHAM (control group,
n
= 28). The percentage of total weight loss (%TWL), coprocalorimetry, glucose and insulin tolerance test, insulin, GLP-1, PYY, and GIP before and after surgery were assessed. The animals were followed over 6 months (equivalent to 16 years in humans).
Results
At 6 months, %TWL was significantly greater(
p
= 0.025) in the SG-TB group compared to the RYGB group. There was no difference between the groups (
p
= 0.86) in malabsorption 15 and 120 days postoperatively. Glucose tolerance was significantly improved (
p
= 0.03) in the SG-TB and RYGB groups compared to the preoperative state. Insulin secretion, at 3 months, was significantly more important in the SG-TB group (
p
= 0.0003), compared to the RYGB and SHAM groups. GLP-1 secretion was significantly increased in the SG-TB and RYGB groups compared to the preoperative state (
p
= 0.001) but similar between SG-TB and RYGB animals (
p
= 0.72).
Conclusion
In a rat model, at long term compared to RYGB, SG-TB provides greater and better-maintained weight loss and an increased insulin secretion without impairing nutritional status
.
Graphical Abstract</description><subject>Animal biology</subject><subject>Animals</subject><subject>Gastrectomy</subject><subject>Gastric Bypass</subject><subject>Gastrointestinal surgery</subject><subject>Glucagon-Like Peptide 1</subject><subject>Glucose</subject><subject>Humans</subject><subject>Insulin</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Nutritional Status</subject><subject>Obesity - surgery</subject><subject>Obesity, Morbid - surgery</subject><subject>Original Contributions</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Retrospective Studies</subject><subject>Surgery</subject><subject>Treatment Outcome</subject><subject>Weight Loss</subject><issn>0960-8923</issn><issn>1708-0428</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kc1u1DAUhSMEokPhBVggS2xgYfBPYo-X01FpkQYqtWXByrpJ7I6rJJ7aTiEPxTvimZQisWBl-d7vnGP5FMVrSj5QQuTHSKlQFSaMYyJKKbF8UiyoJEtMSrZ8WiyIEgQvFeNHxYsYbwlhVDD2vDjiQjLFBV8Uv1YDdFN0EXmL0tagU2tdA82EYGgPg40fbnAyoUdfTILad6457L6OKbjkfNajqwRpPFhcdcbcG3QGMQXTJN9P6IdLW3QdYIguoRO3g5AOOrT2fb6YHOPRpR9_YjPg77M0Z5xMO4gRuQFd1CYadAkpviyeWeiiefVwHhffPp1er8_x5uLs83q1wQ0XJOGKQsstVbJsQIGtGqVaoMrWUDGoDVSVFKQ0VVlKKiwvm7a1IISRnNXAbcWPi_ez7xY6vQuuhzBpD06frzZ6PyNcSUoVu6eZfTezu-DvRhOT7l1sTNfBYPwYNZOSqrIkdI--_Qe99WPIH7inlBC5FcEzxWaqCT7GYOzjCyjR--L1XLzOxetD8Vpm0ZsH67HuTfso-dN0BvgMxLwabkz4m_0f29-MU7oq</recordid><startdate>20230401</startdate><enddate>20230401</enddate><creator>Baratte, Clement</creator><creator>Willemetz, Alexandra</creator><creator>Ribeiro-Parenti, Lara</creator><creator>Carette, Claire</creator><creator>Msika, Simon</creator><creator>Bado, Andre</creator><creator>Czernichow, Sebastien</creator><creator>Le Gall, Maude</creator><creator>Poghosyan, Tigran</creator><general>Springer US</general><general>Springer Nature B.V</general><general>Springer Verlag</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0002-7103-1088</orcidid><orcidid>https://orcid.org/0000-0002-5372-4585</orcidid></search><sort><creationdate>20230401</creationdate><title>Analysis of the Efficacy and the Long-term Metabolic and Nutritional Status of Sleeve Gastrectomy with Transit Bipartition Compared to Roux-en-Y Gastric Bypass in Obese Rats</title><author>Baratte, Clement ; Willemetz, Alexandra ; Ribeiro-Parenti, Lara ; Carette, Claire ; Msika, Simon ; Bado, Andre ; Czernichow, Sebastien ; Le Gall, Maude ; Poghosyan, Tigran</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c360t-51ad3f1974ca9af5c99da19fba52abea557604e544716f34cddfa66e732ba3f53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Animal biology</topic><topic>Animals</topic><topic>Gastrectomy</topic><topic>Gastric Bypass</topic><topic>Gastrointestinal surgery</topic><topic>Glucagon-Like Peptide 1</topic><topic>Glucose</topic><topic>Humans</topic><topic>Insulin</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Nutritional Status</topic><topic>Obesity - surgery</topic><topic>Obesity, Morbid - surgery</topic><topic>Original Contributions</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Retrospective Studies</topic><topic>Surgery</topic><topic>Treatment Outcome</topic><topic>Weight Loss</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Baratte, Clement</creatorcontrib><creatorcontrib>Willemetz, Alexandra</creatorcontrib><creatorcontrib>Ribeiro-Parenti, Lara</creatorcontrib><creatorcontrib>Carette, Claire</creatorcontrib><creatorcontrib>Msika, Simon</creatorcontrib><creatorcontrib>Bado, Andre</creatorcontrib><creatorcontrib>Czernichow, Sebastien</creatorcontrib><creatorcontrib>Le Gall, Maude</creatorcontrib><creatorcontrib>Poghosyan, Tigran</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Obesity surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Baratte, Clement</au><au>Willemetz, Alexandra</au><au>Ribeiro-Parenti, Lara</au><au>Carette, Claire</au><au>Msika, Simon</au><au>Bado, Andre</au><au>Czernichow, Sebastien</au><au>Le Gall, Maude</au><au>Poghosyan, Tigran</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Analysis of the Efficacy and the Long-term Metabolic and Nutritional Status of Sleeve Gastrectomy with Transit Bipartition Compared to Roux-en-Y Gastric Bypass in Obese Rats</atitle><jtitle>Obesity surgery</jtitle><stitle>OBES SURG</stitle><addtitle>Obes Surg</addtitle><date>2023-04-01</date><risdate>2023</risdate><volume>33</volume><issue>4</issue><spage>1121</spage><epage>1132</epage><pages>1121-1132</pages><issn>0960-8923</issn><eissn>1708-0428</eissn><abstract>Purpose
Sleeve gastrectomy with transit bipartition (SG-TB) could be an attractive alternative to Roux-en-Y gastric bypass (RYGB) on weight loss and improvement of comorbidities in patients with obesity. However, there is little long-term data. Translational research on a rat model could allow long-term projection to assess efficacy and safety of SG-TB. The aim of this research was to evaluate the long-term efficacy and safety of SG-TB compared to RYGB and SHAM in rat model.
Materials and Methods
Ninety-four male obese Wistar rats were distributed into 3 groups: SG-TB (
n
= 34), RYGB (
n
= 32), and SHAM (control group,
n
= 28). The percentage of total weight loss (%TWL), coprocalorimetry, glucose and insulin tolerance test, insulin, GLP-1, PYY, and GIP before and after surgery were assessed. The animals were followed over 6 months (equivalent to 16 years in humans).
Results
At 6 months, %TWL was significantly greater(
p
= 0.025) in the SG-TB group compared to the RYGB group. There was no difference between the groups (
p
= 0.86) in malabsorption 15 and 120 days postoperatively. Glucose tolerance was significantly improved (
p
= 0.03) in the SG-TB and RYGB groups compared to the preoperative state. Insulin secretion, at 3 months, was significantly more important in the SG-TB group (
p
= 0.0003), compared to the RYGB and SHAM groups. GLP-1 secretion was significantly increased in the SG-TB and RYGB groups compared to the preoperative state (
p
= 0.001) but similar between SG-TB and RYGB animals (
p
= 0.72).
Conclusion
In a rat model, at long term compared to RYGB, SG-TB provides greater and better-maintained weight loss and an increased insulin secretion without impairing nutritional status
.
Graphical Abstract</abstract><cop>New York</cop><pub>Springer US</pub><pmid>36729363</pmid><doi>10.1007/s11695-023-06477-7</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-7103-1088</orcidid><orcidid>https://orcid.org/0000-0002-5372-4585</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0960-8923 |
| ispartof | Obesity surgery, 2023-04, Vol.33 (4), p.1121-1132 |
| issn | 0960-8923 1708-0428 |
| language | eng |
| recordid | cdi_hal_primary_oai_HAL_hal_03971192v1 |
| source | MEDLINE; SpringerNature Journals |
| subjects | Animal biology Animals Gastrectomy Gastric Bypass Gastrointestinal surgery Glucagon-Like Peptide 1 Glucose Humans Insulin Life Sciences Male Medicine Medicine & Public Health Nutritional Status Obesity - surgery Obesity, Morbid - surgery Original Contributions Rats Rats, Wistar Retrospective Studies Surgery Treatment Outcome Weight Loss |
| title | Analysis of the Efficacy and the Long-term Metabolic and Nutritional Status of Sleeve Gastrectomy with Transit Bipartition Compared to Roux-en-Y Gastric Bypass in Obese Rats |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T20%3A38%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Analysis%20of%20the%20Efficacy%20and%20the%20Long-term%20Metabolic%20and%20Nutritional%20Status%20of%20Sleeve%20Gastrectomy%20with%20Transit%20Bipartition%20Compared%20to%20Roux-en-Y%20Gastric%20Bypass%20in%20Obese%20Rats&rft.jtitle=Obesity%20surgery&rft.au=Baratte,%20Clement&rft.date=2023-04-01&rft.volume=33&rft.issue=4&rft.spage=1121&rft.epage=1132&rft.pages=1121-1132&rft.issn=0960-8923&rft.eissn=1708-0428&rft_id=info:doi/10.1007/s11695-023-06477-7&rft_dat=%3Cproquest_hal_p%3E2796667263%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2796667263&rft_id=info:pmid/36729363&rfr_iscdi=true |